Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lunec

Showing results (221-230 of 227) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 227 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell linesM J Barnes, E J Estlin, G A Taylor, et al.
British Journal of Cancer|June 13, 2014
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastomaL Chen, Y Zhao, G C Halliday, et al.
Journal of Clinical Pathology|August 7, 2008
Histological profile of tumours from MYCN transgenic miceH C Moore, K M Wood, M S Jackson, et al.
Regulatory Toxicology and Pharmacology : RTP|November 26, 2008
Multicenter study to assess potential hazards from exposure to lipid peroxidation products in soya bean oil from Trilucent breast implantsG M Williams, J Caldwell, D Armstrong, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismG J Peters, H H J Backus, S Freemantle, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.
Pageof 23

Showing results (221-230 of 227) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 227 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell linesM J Barnes, E J Estlin, G A Taylor, et al.
British Journal of Cancer|June 13, 2014
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastomaL Chen, Y Zhao, G C Halliday, et al.
Journal of Clinical Pathology|August 7, 2008
Histological profile of tumours from MYCN transgenic miceH C Moore, K M Wood, M S Jackson, et al.
Regulatory Toxicology and Pharmacology : RTP|November 26, 2008
Multicenter study to assess potential hazards from exposure to lipid peroxidation products in soya bean oil from Trilucent breast implantsG M Williams, J Caldwell, D Armstrong, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismG J Peters, H H J Backus, S Freemantle, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.
Pageof 23